Skip to main content
Top

Chinese Journal of Cancer Research

Issue 3/2010

Content (12 Articles)

Original Article

Long-term outcome of a large series of gastric cancer patients in China

Ai-wen Wu, Jia-fu Ji, Hong Yang, Yan-ning Li, Shuang-xi Li, Lian-hai Zhang, Zi-yu Li, Xiao-jiang Wu, Xiang-long Zong, Zhao-de Bu, Ji Zhang, Xiang-qian Su, Yi Wang, Guang-wei Xu

Original Article

Anorectal malignant melanoma: Diagnosis and treatment of 42 cases

Xiao-bin Li, Lin Shi, Shuang-min Zhang

Original Article

Expressions of poly (ADP-ribose) glycohydrolase (PARG) and membrane type 1 matrix metalloproteinase (MT1-MMP) in colorectal carcinoma

Xian Li, Guang-jie Duan, Ya-lan Wang, N. Jasmine Fauzee, Qiao-zhuan Li

Original Article

FHL2 antagonizes Id1-promoted proliferation and invasive capacity of human MCF-7 breast cancer cells

Wei-dong Han, Zhi-qiang Wu, Ya-li Zhao, Yi-ling Si, Ming-zhou Guo, Xiao-bing Fu

Original Article

Circulating tumor cells in metastatic breast cancer: Monitoring response to chemotherapy and predicting progression-free survival

Jian-ping Cheng, Ying Yan, Xiang-yi Wang, Yuan-li Lu, Yan-hua Yuan, Xiao-li Wang, Jun Jia, Jun Ren

Original Article

Identification and characterization of side population cells in human lung adenocarcinoma SPC-A1 cells

Zhu Yan-liang, Chen Long-bang, Wang Jing-hua, Xia Xin-yi

Original Article

Detection of human papilloma virus type 16 E6 mRNA in laryngeal squamous cell carcinoma by in situ hybridization

Jiang Hai-rong, Wang Peng, Li Yong, Ning Tao, Rao Xiao-song, Liu Bao-guo

Case Report

Small-cell carcinoma of prostate: A case report and literature review

Feng Sun, Chun-lin Chen, Rong-jian Chen, Ai-e Liu, Ling Ding, Xiao-zhe Cao

Case Report

Cervical adenosarcoma: Report of a case and literature review

Kun Zhang, Jin-song Han, Fidelia Mbi

Case Report

Primary testicular NK/T-cell lymphoma: A study of two cases and review of literature

Xiao Lin, Dan Li, Peng Xie, Can Mi, Qing Lin

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine